BRUKINSA vs SORAFENIB TOSYLATE

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated June 7, 2026·How we rate

Possible drug interaction. BRUKINSA and SORAFENIB TOSYLATE are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	BRUKINSA	SORAFENIB TOSYLATE
Rating	New	New
Pharmacy pays	—	—
Type	RX	RX
Active ingredient	ZANUBRUTINIB	SORAFENIB TOSYLATE
Manufacturer	Beone Medicines USA	Yabao Pharm
Dosage forms	Capsule, Tablet	Tablet
Drug class	Kinase Inhibitor	Kinase Inhibitor
Boxed warning	None	None
Treats	Mantle-Cell Lymphoma	Renal Cell Carcinoma, Hepatocellular Carcinoma, Thyroid Neoplasms

brukinsa sorafenib tosylate

Rating

New

Pharmacy pays

—

Type

Active ingredient

ZANUBRUTINIB

SORAFENIB TOSYLATE

Manufacturer

Beone Medicines USA

Yabao Pharm

Dosage forms

Capsule, Tablet

Tablet

Drug class

Kinase Inhibitor

Boxed warning

None

Treats

Mantle-Cell Lymphoma

Renal Cell Carcinoma, Hepatocellular Carcinoma, Thyroid Neoplasms

Frequently asked questions

What is the difference between Brukinsa and Sorafenib Tosylate?

Brukinsa contains Zanubrutinib, while Sorafenib Tosylate contains Sorafenib Tosylate — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.